Albert J. Robichaud
InvestorPartner at Cure Ventures · Executive Officer at Sage Therapeutics
Cambridge, Massachusetts, United States
Find your path to Albert
607 people in our graph share verified history with Albert — schools, employers, funds. One of them is your warm intro.
Lawrence BettinounlockedAlbert: together at Rensselaer Polytechnic Institute (1978–1982)
Albert: together at DuPont Pharmaceuticals
×4Albert: together at Wyeth pharmaceuticals
×3Albert: together at DuPont Merck Pharma
About
Partner with over three decades in neuroscience drug discovery. Founding scientist and Chief Scientific Officer at Sage Therapeutics, contributing to approved CNS drugs Zulresso and Zurzuvae, with prior roles at Lundbeck and Wyeth.
Contact· self-published, not guessed
Executive Officer at Sage Therapeutics
Intro paths
→
In turn, Albert can intro founders to Sage Therapeutics's investors below.
Sage Therapeutics's investors · 2
Experience
- Tortugas NeurosciencePresident and Head of Research and Developmentcurrent2026 — present
- Cure VenturesVenture Partner2026
- Cure VenturesPartner2024 — 2026Boston, Massachusetts, United States
- 73 R&D ConsultingScientist2023 — 2024United States
- Sage TherapeuticsChief Scientific Officer2011 — 2023Cambridge, MA
- Lundbeck Research, USAVice President2010 — 2011
- Wyeth pharmaceuticalsSenior Director; Head of Princeton Chemistry Dept2002 — 2010
- Bristol-Myers SquibbDirector2001 — 2002
- DuPont PharmaceuticalsDirector1999 — 2001
- DuPont Merck PharmaDirector1997 — 1999
- Merck PharmaResearch Fellow1991 — 1997
- FMCStaff Chemist1982 — 1984
Skills & more
Medicinal Chemistry90Lead Change25Organic Chemistry61Drug Discovery53Neuroscience53Biotechnology18Biochemistry4ADME2Clinical Development4Chemistry26Analytical Chemistry2Assay Development3
+3 more
Drug DesignDrug DevelopmentHPLCFrom Albert's professional profile.
Colleagues at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures
Frequently asked questions
- Who is Albert J. Robichaud?
- Partner with over three decades in neuroscience drug discovery. Founding scientist and Chief Scientific Officer at Sage Therapeutics, contributing to approved CNS drugs Zulresso and Zurzuvae, with prior roles at Lundbeck and Wyeth.
- Where does Albert J. Robichaud work?
- Albert J. Robichaud is Partner at Cure Ventures.
- Where did Albert J. Robichaud go to school?
- Albert J. Robichaud studied at Colorado State University (Post Doctoral Fellow, Organic Chemistry); UC Irvine (PhD, Organic Chemistry); Rensselaer Polytechnic Institute (B.S., Chemistry).
Same school
Also attended Colorado State University146
Paul OsmundsonVice President Strategy & Innovation - ARUP Laboratories at EPIC VENTURESTim WeelborgGeneral Partner and co-founder of Homegrown CapitalSophia SorensenOffice Coordinator at Sorenson VenturesBraden DeforgeWealth Management Associate at Goalvest VentureLarry BurgessExecutives in Residence at GENERAL INCEPTIONSamantha GuinnAnalyst at Novartis Venture Fund
+ 140 more
Also attended UC Irvine262
Christian BuergerPortfolio Development at Intel CapitalJonathan GiegCommunity Manager at Pantera CapitalRyan LaurinManaging Director at Marlin Equity PartnersChristopher WestSenior Legal Counsel at Qualcomm VenturesPascal KroteePrincipal, Ph.D. at RiverVest Venture PartnersZack IsaacsonVenture Partner at Rackhouse Venture Management Lp
+ 256 more
Also attended Rensselaer Polytechnic Institute205
Lawrence BettinoManaging Director at Dot CapitalPatch PaczkowskiVenture Partner at IronGate Capital AdvisorsJonathan BurbaumEntrepreneur-In-Residence at The Innovation SpaceAaron HenshawInvestor at Ambush CapitalCarly StrifeInvestor at Ambush CapitalJoe LallouzEntrepreneur and angel investor based in New York City
+ 199 more
Shared employers
Also worked at Tortugas Neuroscience3
Also worked at Sage Therapeutics10
Jeffrey M. JonasPartner at Cure VenturesKiran ReddySenior Managing Director at Blackstone Life SciencesJamil BegPartner at 5AM VenturesAsha NayakInvestor at Johnson & Johnson Innovation – JJDCMatthew CalistriManaging Director at Bain Capital Life SciencesDario DollerCo-founder at Modulate Bio
+ 4 more
Also worked at Wyeth pharmaceuticals402
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 396 more
Also worked at Bristol-Myers Squibb158
Scott BillerInvestor at GV (Google Ventures)Avantika DaingFounding Partner at Plum Alley InvestmentsJake BauerVenture Partner at ARCH Venture PartnersScott DonohueSenior Director, Market Access at Deerfield Management CompanyMellissa GraySenior Scientist, Protein Sciences at Deerfield Management CompanyBeth SeidenbergFounding Managing Director at Westlake Village BioPartners
+ 152 more